Wilbur Lippmann

This inventor holds 12 USPTO granted patents. Top assignees: Ayerst, Mckenna & Harrison, Inc., American Home Products Corporation. Active years: 1976-1983.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wilbur Lippmann. Retrieved from https://idiyas.com/inventor/wilbur-lippmann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12

% Patents Active = 100.0

Average Co-Inventor Count = 1.7

ph-index = 3

Forward Citations = 71(Granted Patents)

Location History:

St. Laurent, CA (1981)
Montreal, CA (1976 - 1983)

Company Filing History:

9 out of 117

Ayerst, Mckenna & Harrison, Inc.

patents

3 out of 1,567

American Home Products Corporation

patents

Years Active: 1976-1983

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4405625 - Method of treating hyperglycemia with (1983-09-20),

2. 4267189 - Method of use and composition for (1981-05-12),

3. 4170653 - Antidepressant naphthyloxy piperidino and pyrrolidino propanol ethers (1979-10-09),

4. 4140779 - Aryloxy propyldiamines (1979-02-20),

5. 4118511 - Aryloxy aminobutanols for alleviating symptoms of depression (1978-10-03),

6. 4118495 - Method of treating hyperglucagonemia with (1978-10-03),

7. 4118493 - Method of treating hyperchlorhydria and/or associated conditions with (1978-10-03),

8. 4071552 - Aryloxy aminobutanols, their preparation and use thereof (1978-01-31),

9. 4070482 - Prostaglandin antagonists (1978-01-24),

10. 4060613 - 3-Aryloxy-2(4-loweralkyl-1-piperazinyl)propanols, their alkylethers, and (1977-11-29),

11. 4004027 - Prostaglandin antagonists (1977-01-18),

12. 3937801 - Reducing the incidence of gastrointestinal side effects during the (1976-02-10),

Title: The Innovative Journey of Wilbur Lippmann

Introduction

Wilbur Lippmann, a prominent inventor based in Montreal, Canada, has made significant contributions to the field of pharmaceuticals through his innovative inventions. With a remarkable portfolio of 12 patents, Lippmann has dedicated his career to developing methods that improve health outcomes, particularly for individuals suffering from various medical conditions.

Latest Patents

Among his most recent patents, Lippmann has focused on treating hyperglycemia. He developed a method for lowering blood glucose levels in diabetic mammals by administering an effective amount of 1,3-dioxo-1H-benz[de]isoquinoline-2(3H)-acetic acid. Additionally, he disclosed pharmaceutical compositions and methods for using 1,3-dihydro-3-(2-hydroxy-2-methylpropyl)-2H-isoindol-1-one to treat ulcers and prevent excessive gastric acid secretion in mammals suffering from hyperchlorhydria and related conditions.

Career Highlights

Lippmann's career is marked by his work with notable companies in the pharmaceutical industry, such as Ayerst, McKenna & Harrison, Inc., and American Home Products Corporation. His efforts in researching and developing effective medical treatments have garnered recognition and respect within the scientific community.

Collaborations

Throughout his career, Wilbur Lippmann has collaborated with esteemed colleagues, including Jean-Marie Ferland and Real R Laliberte. These partnerships have played a crucial role in advancing his innovative projects and enhancing the effectiveness of his inventions.

Conclusion

Wilbur Lippmann has established himself as a notable inventor in the pharmaceutical landscape. His innovative solutions and collaborative efforts have not only contributed to the field of medicine but have also helped countless individuals manage their health more effectively. With a robust patent portfolio and a commitment to improving lives, Lippmann continues to serve as an inspiration to future inventors.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]